Information for Medical Professionals

Research claims calcitonin can benefit osteoarthritis sufferers

New research has showed that calcitonin could be beneficial for patients suffering from cartilage degeneration - such as those suffering from osteoarthritis.

According to the new research paper by Nordic Bioscience, entitled Investigation of the Direct Effect of Salmon Calcitonin on Human Osteoarthritic Chondrocytes, oral salmon calcitonin "may exert a positive effect on joint health through its dual action of promoting both bone and cartilage formation".

Michael Novinski, president and chief executive officer of Emisphere Technologies, said: "The research conducted by Nordic Bioscience is unique and significant as it represents the first work to look chiefly at the ability of salmon calcitonin to stimulate cartilage synthesis."

The researchers behind the study claim that treatment with pharmacological concentrations of calcitonin boosts proteoglycan and collagen type II - both of which are key components in cartilage synthesis.

Last year, researchers from Denmark claimed that a full-scale investigation should be mounted into the benefits of analgesic calcitonin as a means of managing pain in people with musculoskeletal disorders.

---

<< Back

News provided by Adfero in collaboration with Biomet. Please note that all copy is (c) Adfero Ltd and does not reflect the views or opinions of Biomet unless explicitly stated.